Sara Bohon

Sara Bohon

Auto-generated profile, based on publicly available information

Sara Bohon

Division of Pediatric Gastroenterology, Hepatology, and Nutrition University of Virginia Health System Charlottesville Virginia USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2026 in JPGN Reports
Verified
Journal Article
Open access
SBSara Bohon
Sara Bohon
RGRegino Gonzalez‐Peralta
Regino Gonzalez‐Peralta
RFRobert J. Fontana
Robert J. Fontana
RCRichard Cordle
Richard Cordle
RLRobin LeGallo
Robin LeGallo
FDFrank DiPaola
Frank DiPaola
A 12‐year‐old boy presented to our center with elevated aminotransferases, jaundice, right upper quadrant tenderness, and hepatomegaly. Evaluation revealed a highly elevated blood hepatitis C virus (HCV) ribonucleic acid (RNA) level, and liver biopsy showed canalicular and intrahepatic cholestasis, feathery degeneration of hepatocytes, and periportal/perisinusoidal fibrosis. Though there were atypical biopsy features, including absence of bile ductular reaction, we diagnosed suspected fibrosing cholestatic hepatitis (FCH). FCH secondary to HCV infection has been reported exclusively in immunosuppressed adults. To our knowledge, this is the first reported case of suspected FCH in a child, and the first reported case of suspected HCV‐related FCH in any immunocompetent patient. Our patient was successfully treated with sofosbuvir/velpatasvir with sustained virologic response at 12 weeks. We conclude that FCH should be considered on the differential whenever any child with HCV infection presents with evidence of worsening liver injury including new hepatomegaly or jaundice.